Barclays Maintains Equal-Weight on Legence, Lowers Price Target to $60
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
Barclays analyst Adam Seiden maintains Legence (NASDAQ:LGN) with a Equal-Weight and lowers the price target from $80 to $60.
Barclays analyst Adam Seiden maintains Legence (NASDAQ:LGN) with a Equal-Weight and lowers the price target from $80 to $60.